What is BioSafe Technologies?
BioSafe Technologies, Inc. specializes in the creation and distribution of non-toxic pesticide formulations designed to combat parasites and blood-sucking insects affecting both humans and animals. Established in 2000, the company has successfully developed and clinically tested products, including a pesticide-free lice shampoo. This innovative product is primarily exported to Europe for private labeling by major pharmaceutical entities. BioSafe's core business strategy centers on forging partnerships with established international distributors to navigate diverse market regulations and expand its global reach. As a recognized woman-owned business, BioSafe has garnered accolades for its contributions to international exports and advancements in insect control technology.
How much funding has BioSafe Technologies raised?
BioSafe Technologies has raised a total of $29K across 1 funding round:
Debt
$29K
Debt (2021): $29K with participation from PPP
What's next for BioSafe Technologies?
With the recent influx of substantial expansion capital, BioSafe Technologies is poised to accelerate its market penetration and product development initiatives. The company's focus on non-toxic formulations aligns with growing global demand for environmentally conscious pest control solutions. Strategic partnerships with international distributors will likely be a key driver for scaling operations and increasing export volumes, particularly for its successful pesticide-free lice shampoo. Further investment will enable BioSafe to enhance its research and development capabilities, potentially leading to new product lines and expanded applications for its innovative technologies. The company's trajectory suggests a continued emphasis on global market expansion and solidifying its position as a leader in safe and effective insect control.
See full BioSafe Technologies company page
